Log In
BCIQ
Print this Print this
 

CGS-125

  Manage Alerts
Collapse Summary General Information
Company CapGenesis Therapeutics LLC
DescriptionHigh-strength topical trans-capsaicin, a transient receptor potential vanilloid 1 (TRPV1; VR1) agonist
Molecular Target Transient receptor potential vanilloid 1 (TRPV1) (VR1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA) of the knee
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today